Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Atlanta, GA
NPI: 1730147596Primary Practice Location
Piedmont West Ambulatory Surgery Center
1800 Howell Mill Road Northwest, Atlanta, GA
Primary Employer
Piedmont Cancer Institute - Newnan
piedmontcancerinstitute.com
HQ Phone
Get M.D. Vasileios's Phone Numberphone_androidMobile
Get M.D. Vasileios's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
GA State Medical License
2003 - 2025
TX State Medical License
2000 - 2004
IL State Medical License
1996 - 2002
American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center at Houston
Fellowship • Hematology and Medical Oncology
2000 - 2003
Cook County Health and Hospitals System
Residency • Internal Medicine
1996 - 2000
Aristotle University of Thessaloniki School of Medicine
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 489 | 1,474 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 416 | 796 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 271 | 628 |
| 4 | 96413Infusion of chemotherapy into a vein up to 1 hour | 160 | 789 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 148 | 456 |
Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups.
Authors: Michael Carducci, Jay Gingrich, Andrew Armstrong
Publication Date: 2011-03
Neuroendocrine cancer of the kidney: Clinical implications of expression microarray analysis.
Authors: Lin, Bing-Biao, Lei, Han-Qi, Xiong, Hai-Yun, Fu, Xing, Shi, Fu, Yang, Xiang-Wei, Yang, Ya-Fei, Liao, Guo-Long, Feng, Yu-Peng, Jiang, Dong-Gen, Pang, Jun
Journal: Comput Struct Biotechnol J
Publication Date: 2021-08-31
Lead Sponsor: HonorHealth Research Institute
Collaborators: Cancer Research UK, University of Arizona, Translational Genomics Research Institute, Salk Institute for Biological Studies, Stand Up To Cancer, Princeton University, Cold Spring Harbor Laboratory, Lustgarten Foundation, Barts Cancer Institute, Imaging Endpoints
Intervention / Treatment: DRUG: Cisplatin, DRUG: Gemcitabine, DRUG: Ascorbic Acid, DRUG: Paclitaxel protein-bound
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Capecitabine, DRUG: Atorvastatin
